Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$392K Buy
3,051
+9
+0.3% +$1.05K 0.1% 107
2026
Q1
$366K Buy
3,042
+643
+27% +$74.2K 0.11% 108
2025
Q4
$252K Buy
+2,399
New +$225K 0.08% 125

Other funds holding MRK

Balance Wealth's MRK Position: Q2 2026 in Review

Balance Wealth increased its Merck (MRK) stake by 0.3% in Q2 2026, buying an estimated $1.05K and bringing the position to 3,051 shares worth $392K. The position accounts for 0.1% of the portfolio, ranked #107.

Balance Wealth first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Balance Wealth held 3,051 shares of Merck worth $392K as of Q2 2026.
  • Balance Wealth bought 9 Merck shares in Q2 2026, an estimated $1.05K.
  • Merck made up 0.1% of Balance Wealth's portfolio in Q2 2026, its #107 holding.
  • Balance Wealth first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Balance Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.